| # | Drug | Count |
|---|---|---|
| 0 | AZATHIOPRINE | 40 |
| 1 | ADALIMUMAB | 27 |
| 2 | RITUXIMAB | 23 |
| 3 | TACROLIMUS | 23 |
| 4 | METHOTREXATE SODIUM | 22 |
| 5 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 21 |
| 6 | TACROLIMUS OINTMENT 0.1% | 21 |
| 7 | METHOTREXATE | 19 |
| 8 | PREDNISONE | 19 |
| 9 | VEDOLIZUMAB | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID | 2 | 0.0028 |
| 1 | BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE | 2 | 0.0018 |
| 2 | PENICILLAMINE | 1 | 0.0011 |
| 3 | BARICITINIB | 3 | 0.0010 |
| 4 | CLADRIBINE | 8 | 0.0008 |
| 5 | IDARUCIZUMAB | 1 | 0.0007 |
| 6 | IOPAMIDOL | 2 | 0.0007 |
| 7 | VEMURAFENIB | 8 | 0.0007 |
| 8 | CLINDAMYCIN HYDROCHLORIDE | 2 | 0.0006 |
| 9 | IOVERSOL | 2 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 2 | Anti-coagulant [EPC] | 2 | 0.0005 |
| 3 | Purine Antimetabolite [EPC] | 48 | 0.0005 |
| 4 | Actinomycin [EPC] | 1 | 0.0005 |
| 5 | Integrin Receptor Antagonist [EPC] | 28 | 0.0003 |
| 6 | Provitamin D2 Compound [EPC] | 8 | 0.0003 |
| 7 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 8 | Human Immunoglobulin G [EPC] | 5 | 0.0002 |
| 9 | Cephalosporin Antibacterial [EPC] | 2 | 0.0002 |